Gufic Biosciences Limited

NSE:GUFICBIO.NS

400.45 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 861.355797.048958.401442.316228.567219.407160.217180.174111.9165.25962.73452.63129.70114.64112.2788.3648.771
Depreciation & Amortization 170.172222.81171.339163.07683.546.46643.02136.83337.86838.52224.67721.79518.81218.06616.62516.72518.036
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital -1,302.333-1,352.53-102.01699.68770.644-335.174-300.586-284.362-213.146-16.203-1.884-47.43-18.657-48.008-10.7213.58-35.983
Accounts Receivables -1,532.419-553.16-231.931-189.9-167.175-350.812-241.068-123.65-228.44-50.359-81.9236.03100000
Inventory -170.246-678.907-211.623280.568-149.131-0.836-308.665-127.532-134.617-106.86-61.195-30.864-41.427-24.1143.5128.1612.9
Accounts Payables 400.332-120.463341.5399.019274.23116.475244.85214.16566.04500000000
Other Working Capital 00-0.0010112.719-0.0018.079-156.83-78.52990.65759.311-16.56622.77-23.894-14.233-4.58-48.883
Other Non Cash Items 1,722.75866.816.718185.56974.232121.37548.83223.38320.19523.95423.12925.57121.78924.34820.18923.6714.229
Operating Cash Flow -190.725-265.8721,044.442890.648456.94352.074-48.516-43.972-43.173111.532108.65652.56751.6459.04738.37152.3395.053
Investing Activities:
Investments In Property Plant And Equipment -1,126.946-1,876.007-888.017-142.134-401.172-130.838-82.445-34.99-9.708-25.125-39.409-133.794-33.413-22.266-30.994-13.938-4.767
Acquisitions Net 45.6620.3160.68400.1550.050.00202.00800000000
Purchases Of Investments -10-7.768-77.740-32.85-2.947-7.287-6.6110000000-0.550
Sales Maturities Of Investments 0-0.31677.05651.49732.6952.89700000000000
Other Investing Activites 57.351-23.49-71.365.568-23.270.893-5.9171.7694.5741.18511.6291.2310.1521.9521.3490.16263.498
Investing Cash Flow -1,033.933-1,907.265-959.377-85.069-424.442-129.945-88.362-33.221-5.134-23.94-27.78-132.563-33.261-20.314-29.645-14.32658.731
Financing Activities:
Debt Repayment -55.07-2,500.92-60.775-767.79-126.403-66.166-19.999-8.881-38.394-33.847-35.515-140.9800000
Common Stock Issued 999.90000000000000000
Common Stock Repurchased 00000000000000000
Dividends Paid -9.694-10.437-9.211-3.629-4.875-3.875-3.876-3.868-3.868-3.868-3.868-3.698-3.857-3.815-3.798-7.60
Other Financing Activities -5.64,854.43338.988-14.761104.002147.135168.73983.61290.094-13.23-28.86186.85-14.37513.7571.008-38.971-55.217
Financing Cash Flow 950.0072,343.076-30.998-786.18-27.27677.094144.86470.86347.832-50.945-68.24483.152-18.2329.942-2.79-46.571-55.217
Other Information:
Effect Of Forex Changes On Cash 00-0.0010.0010.7740.001-0.001000.001000000.0020
Net Change In Cash -151.403169.93954.06719.45.223-0.7777.985-6.33-0.47536.64812.6323.1560.152-1.3255.936-8.5568.567
Cash At End Of Period 134.84286.019116.08162.01441.83836.61536.71255.25961.5962.06325.41412.7839.6279.47510.84.86413.42